Skip to main content

Find Clinical Trials

Home
Conditions
Pulmonary Fibrosis

Clinical trial condition

Pulmonary Fibrosis

Explore clinical trials studying Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

127 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Pulmonary Fibrosis trial results

Completed

Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients

NCT01335464

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: 1199.32.10007 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States

1199.32.10029 Boehringer Ingelheim Investigational Site Jasper, Alabama, United States

1199.32.10013 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States

1199.32.10005 Boehringer Ingelheim Investigational Site Los Angeles, California, United States

View all 98 locations

View Trial Details

Completed

Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases

NCT00005317

Conditions: Connective Tissue Diseases, Fibrosis, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Completed

Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology

NCT01687946

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: Medical University of Vienna Vienna, Austria

View Trial Details

Completed

Linkage Study in Familial Pulmonary Fibrosis

NCT00016627

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: Not specified

View Trial Details

Completed

Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis

NCT02668029

Conditions: Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +4 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT00786201

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: Birmingham, Alabama, United States

Phoenix, Arizona, United States

Miami, Florida, United States

Tampa, Florida, United States

View all 30 locations

View Trial Details

Completed

Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

NCT00517933

Conditions: Cardiovascular Diseases, Fibrosis, Hypertension, +9 more
Locations: University of Alabama - Birmingham Birmingham, Alabama, United States

University of California - Los Angeles Los Angeles, California, United States

University of California - San Francisco San Francisco, California, United States

National Jewish Medical and Research Center Denver, Colorado, United States

View all 13 locations

View Trial Details

Completed

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

NCT00650091

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: University of Alabama - Birmingham Birmingham, Alabama, United States

University of California - Los Angeles Los Angeles, California, United States

University of California - San Francisco San Francisco, California, United States

National Jewish Medical and Research Center Denver, Colorado, United States

View all 26 locations

View Trial Details

Completed

Scleroderma Lung Disease

NCT00004563

Conditions: Connective Tissue Diseases, Fibrosis, Lung Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF)

NCT00639496

Conditions: Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations: U.Z. Ghent Ghent, Belgium

Hôpital A. Calmette Lille, France

Klinikum Grosshadern Munich, Germany

U.O. di Pneumologia-Ospedale Arezzo, Italy

View Trial Details